RxDoctor Payments Data

Richard Fries, MD

Vascular Surgery · Cincinnati, OHNPI 1033321567

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (39.9%), other and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Shockwave Medical, Inc at 50.0% of the total. Reporting peaked in 2023 at $16,904 and has fallen 62.8% since, to $6,288 in 2025. Among vascular surgery clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,066in general payments, 2019–2025

Across 135 payments — averaging $244.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shockwave Medical, Inc$17K
  • Angiodynamics, Inc.$10K
  • Penumbra, Inc.$2K
  • Imperative Care, Inc$1K
  • Silk Road Medical, Inc.$573
  • Boston Scientific$488
  • plus $2K from 23 others
$4,681in research payments, 2019–2025

Across 3 payments — averaging $1560.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$2K
  • Biocompatibles, Inc.$2K

What the payments were for

  • Speaking & faculty fees$13,20040%
  • Travel & lodging$4,97815%
  • Food & beverage$4,97115%
  • Other$9,91730%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,066 in reported general payments places this provider in the 90th percentile of 213 vascular surgery providers in Ohio.

See all vascular surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$177,047
Medicare patients
621
Services billed
1,235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate120$774
Oxycodone Hcl125$448
Cilostazol37$437

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →